Related Experiment Video
Updated: Oct 9, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Maternal opioid use is reflected on leukocyte telomere length of male newborns
Fatemeh Rahimi Mehdi Abad1, Parvin Khalili2,3, Fatemeh Jalali4,5
1Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Insights
Maternal opioid use may impact infant aging. Newborn males born to mothers using opioids showed longer telomere length, a biomarker of aging, suggesting potential transgenerational effects.
Area of Science:
- Gerontology
- Developmental Biology
- Epigenetics
Background:
- Opioid use is known to accelerate aging in adults.
- The transgenerational impact of opioid use on aging biomarkers in offspring is largely unknown.
- Telomere length is a critical biomarker for aging and age-related diseases.
Purpose of the Study:
- To investigate the association between maternal opioid use and relative telomere length (RTL) in newborns.
- To explore potential transgenerational effects of opioid exposure on aging biomarkers at birth.
Main Methods:
- A case-control study involving 57 mother-newborn dyads.
- Measurement of RTL in leukocyte genomic DNA from umbilical cord blood using real-time PCR.
- Logistic regression analysis to assess the correlation between maternal opioid use and neonatal RTL, stratified by neonate sex.
Main Results:
- A significant association was observed between maternal opioid use and longer leukocyte RTL in male neonates.
- Sensitivity analysis by neonate sex revealed that male neonates born to opioid-using mothers had a significantly increased odds ratio of longer RTL.
- No significant association was found in female neonates.
Conclusions:
- Maternal opioid use may be associated with altered telomere length in newborns, particularly in males.
- This finding suggests a potential sex-specific transgenerational influence of opioid exposure on aging biomarkers.
- Further research with larger sample sizes is needed to confirm these findings and elucidate underlying mechanisms.
Abstract:
Opioid use accelerates normal aging in adults that raises a question on whether it may trans-generationally affect aging and aging biomarkers in the offspring of users as well? In the present research, we investigated the relative telomere length in umbilical cord blood of newborns born to opioid consuming mothers compared to normal controls. Telomere length shortening is a known biomarker of aging and aging related diseases. Its measure at birth or early in life is considered as a predictor of individual health in adulthood. Here, we performed a case-control study to investigate whether maternal opioid use affects newborns relative telomere length (RTL). 57 mother-newborn dyads were included in this study, 30 neonates with opioid using mothers (OM), and 27 with not-opioid using mothers (NOM)). RTL was measured in leukocyte cells genomic DNA using real-time PCR. The correlation of maternal opioid use with neonates telomer length was assessed using logistic regression analysis. The results displayed a significant association between odds ratio of long RTL and maternal opioid use when sensitivity analysis was performed by neonate sex; where the data indicates significantly increased odds ratio of long leukocyte RTL in association with maternal opioid use in male neonates only. Further work is necessary to assess this association in larger samples and test the potential underlying mechanisms for this observation.
Related Concept Videos
Animal Mitochondrial Genetics
Analgesia and Pain Management

